In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

Antisense Therapeutics Limited Balance Sheet Statement - Assets

As of 30 Jun 2020, The total current assets of Antisense Therapeutics Limited (ASX:ANP) was around $5,214,099 which consisted of $4,059,442 of Cash, no Inventory and $689,315 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in AUD

Cash
$4.06M
Current assets
$5.21M
Total assets
$5.35M

The latest balance sheet of Antisense Therapeutics Limited also showed $138,119 of Property Plant Equipment and no Good will. Also there were no Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $5,352,218.

Antisense Therapeutics Limited Balance Sheet Statement - Liabilities

ANP's latest annual results shows the balance sheet has $107,866 of Accounts Payable. Also there were no Short/Long term debt, no Long term debt, $4,577 of Other Current liabilities and $798,539 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$107.87k
Current liabilities
$798.54k
Total liabilities
$821.23k

As per the 30 Jun 2020's annual report of Antisense Therapeutics Limited, the total liabilities were $821,229.

ANP Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of Antisense Therapeutics Limited showed the total stock holder equity was $4,530,989 which consisted of $69,147,843 of Common stocks, $-67,036,940 of Retained earnings and $2,420,086 of Other stock holder equity.

ANP Balance Sheet Statement History

Following table shows the history of balance sheet for Antisense Therapeutics Limited (ANP).

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Cash4.06M2.9M1.9M1.9M
Net Receivables689.32k606.47k331.16k427.89k
Inventory----
Total Current Assets5.21M3.7M4.79M2.52M
Property Plant Equipment138.12k2.3k7.67k14.09k
Good Will----
Intangible Assets----
Other Assets----
Deferred Long Term Asset Charges----
Total Assets5.35M3.7M4.8M2.54M
Accounts Payable107.87k227.13k103.75k165.69k
Short/Long Term Debt----
Other Current Liabilities4.58k4.58k4.58k4.58k
Long Term Debt----
Other Liabilities-9.08k--
Total Current Liabilities798.54k879.75k580.86k685.65k
Total Liabilities821.23k888.84k580.86k685.65k
Common Stock69.15M63.94M62.41M57.71M
Retained Earnings-67.04M-61.13M-58.18M-55.85M
Treasury Stock2.42M---
Other Stockholder Equity2.42M---
Total Stockholder Equity4.53M2.81M4.22M1.85M
Net Tangible Assets4.53M2.81M4.22M1.85M

Antisense Therapeutics Limited (ASX:ANP) Balance Sheet Statement FAQ

1. How much Cash Antisense Therapeutics Limited has on their balance sheet?

As of 30 Jun 2020, Antisense Therapeutics Limited (ASX:ANP) has $4,059,442 of Cash.

2. What's the long term debt of Antisense Therapeutics Limited?

As per the latest Balance sheet of Antisense Therapeutics Limited (ASX:ANP), it has no Long term debt.

3. How much share holder equity does Antisense Therapeutics Limited has?

The Antisense Therapeutics Limited (ASX:ANP)'s balance sheet shows that it has $4,530,989 of Total stock holder equity.